Juvena Therapeutics, Inc. — Form D
Juvena Therapeutics, Inc. of REDWOOD CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-25. The offering totals $41.0M, of which $30.5M was reported sold. Industry: Other Technology.
Offering
- Filed: 2025-07-25
- Form: D
- Accession: 0001168404-25-000004
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $41.0M
- Amount sold: $30.5M
- Remaining: $10.5M
- Investors: 12
- Date of first sale: 2025-06-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-552759
Issuer
- Name: Juvena Therapeutics, Inc.
- CIK: 0001732720
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 640 GALVESTON DRIVE, REDWOOD CITY, CA, 94063
- Phone: 914-560-6536
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Ayman AlAbdallah | Director | REDWOOD CITY, CA |
| Ben Hemani | Director | San Francisco, CA |
| Steven James | Director | REDWOOD CITY, CA |
| Stephen Juelsgaard | Director | REDWOOD CITY, CA |
| Christopher Kirk | Director | REDWOOD CITY, CA |
| Laura Lande-Diner | Director | REDWOOD CITY, CA |
| Jeremy O'Connell | Director | REDWOOD CITY, CA |
| Hanadie Yousef | Director | REDWOOD CITY, CA |
| Hanadie Yousef | Executive Officer | REDWOOD CITY, CA |
Other filings by this issuer (1)
More